Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to evaluate the efficacy, safety, and tolerability of 800 and 1,200 mg/day of carisbamate compared with placebo in reducing the average daily pain in subjects with diabetic peripheral neuropathy (DPN).
Inclusion criteria
- Neuropathic Pain in Diabetic Peripheral Neuropathy